MXPA05006685A - Antibioticos que contienen complejos de acido borinico y metodos de uso. - Google Patents
Antibioticos que contienen complejos de acido borinico y metodos de uso.Info
- Publication number
- MXPA05006685A MXPA05006685A MXPA05006685A MXPA05006685A MXPA05006685A MX PA05006685 A MXPA05006685 A MX PA05006685A MX PA05006685 A MXPA05006685 A MX PA05006685A MX PA05006685 A MXPA05006685 A MX PA05006685A MX PA05006685 A MXPA05006685 A MX PA05006685A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- antibiotics
- acid complexes
- borinic acid
- antibiotics containing
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title abstract 4
- 229940088710 antibiotic agent Drugs 0.000 title abstract 4
- UYANAUSDHIFLFQ-UHFFFAOYSA-N borinic acid Chemical class OB UYANAUSDHIFLFQ-UHFFFAOYSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000003899 bactericide agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000417 fungicide Substances 0.000 abstract 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical class OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 abstract 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43437502P | 2002-12-18 | 2002-12-18 | |
| US43609502P | 2002-12-23 | 2002-12-23 | |
| US43784903P | 2003-01-03 | 2003-01-03 | |
| PCT/US2003/040982 WO2004056322A2 (en) | 2002-12-18 | 2003-12-18 | Antibiotics containing borinic acid complexes and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05006685A true MXPA05006685A (es) | 2005-12-14 |
Family
ID=32686073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05006685A MXPA05006685A (es) | 2002-12-18 | 2003-12-18 | Antibioticos que contienen complejos de acido borinico y metodos de uso. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20040224923A1 (enExample) |
| EP (2) | EP1581500A4 (enExample) |
| JP (2) | JP2006511613A (enExample) |
| KR (1) | KR20050084378A (enExample) |
| CN (1) | CN101928295A (enExample) |
| AU (1) | AU2003299821B2 (enExample) |
| BR (1) | BR0317564A (enExample) |
| CA (1) | CA2509645A1 (enExample) |
| MX (1) | MXPA05006685A (enExample) |
| NZ (1) | NZ540870A (enExample) |
| WO (1) | WO2004056322A2 (enExample) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2473238A1 (en) | 2002-01-10 | 2003-07-24 | The Penn State Research Foundation | Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids |
| US7390806B2 (en) * | 2002-12-18 | 2008-06-24 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
| CA2509645A1 (en) * | 2002-12-18 | 2004-07-08 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
| AR049915A1 (es) * | 2004-06-14 | 2006-09-13 | Anacor Pharmaceuticals Inc | Compuestos con contenido de boro y metodos de uso de los mismos |
| AR049916A1 (es) * | 2004-06-14 | 2006-09-13 | Anacor Pharmaceuticals Inc | Usos anti-parasitarios de complejos de acido borinico |
| US7393856B2 (en) | 2004-06-14 | 2008-07-01 | Anacor Pharmaceuticals, Inc. | Anti-viral uses of borinic acid complexes |
| AU2006214247C1 (en) | 2005-02-16 | 2012-11-08 | Anacor Pharmaceuticals, Llc | Boron-containing small molecules |
| US20060217347A1 (en) * | 2005-03-24 | 2006-09-28 | David Perry | Topical formulations of borinic acid antibiotics and their methods of use |
| WO2007079119A2 (en) * | 2005-12-28 | 2007-07-12 | Anacor Pharmaceuticals, Inc. | Process for manufacturing picolinate borinic esters |
| BRPI0621279B1 (pt) | 2005-12-30 | 2021-07-20 | Anacor Pharmaceuticals, Inc | Moléculas pequenas contendo boro |
| CA2642583C (en) | 2006-02-16 | 2016-08-23 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-inflammatory agents |
| WO2007146965A2 (en) * | 2006-06-12 | 2007-12-21 | Anacor Pharmaceuticals, Inc. | Compounds for the treatment of periodontal disease |
| US20070286822A1 (en) * | 2006-06-12 | 2007-12-13 | Anacor Pharmaceuticals Inc. | Compounds for the Treatment of Periodontal Disease |
| WO2008064345A2 (en) * | 2006-11-22 | 2008-05-29 | Anacor Pharmaceuticals, Inc. | Microorganism killing compounds |
| CN102014927A (zh) | 2008-03-06 | 2011-04-13 | 安纳考尔医药公司 | 作为抗炎药的含硼的小分子 |
| EP2285384A4 (en) * | 2008-05-12 | 2012-04-25 | Anacor Pharmaceuticals Inc | BORN SMALL MOLECULES |
| WO2010028005A1 (en) | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
| WO2010027975A1 (en) | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
| US9493489B2 (en) | 2008-10-15 | 2016-11-15 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agents |
| AU2009335744A1 (en) * | 2008-12-17 | 2010-07-15 | Anacor Pharmaceuticals, Inc. | Polymorphs of (S)-3-aminomethyl-7-(3-hydroxy-propoxy) -3H-benzo[c][1,2] oxaborol-1-ol |
| JP2013500974A (ja) * | 2009-07-28 | 2013-01-10 | アナコール ファーマシューティカルズ，インコーポレイテッド | 三置換ホウ素含有分子 |
| AP4039A (en) | 2009-08-14 | 2017-02-28 | Daitao Chen | Boron-containing small molecules as antiprotozoal agents |
| MX2012002031A (es) * | 2009-08-19 | 2012-07-04 | Anacor Pharmaceuticals Inc | Moleculas pequeñas que contienen boro como agentes antiprotozoarios. |
| US20110124597A1 (en) * | 2009-09-25 | 2011-05-26 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules |
| US9346834B2 (en) | 2009-10-20 | 2016-05-24 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
| WO2011060199A1 (en) * | 2009-11-11 | 2011-05-19 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
| WO2011094450A1 (en) | 2010-01-27 | 2011-08-04 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules |
| WO2011116348A1 (en) | 2010-03-19 | 2011-09-22 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agent |
| SMT202100643T1 (it) | 2010-09-07 | 2022-01-10 | Anacor Pharmaceuticals Inc | Derivati del benzossaborolo per il trattamento delle infezioni batteriche |
| US8669207B1 (en) | 2013-01-30 | 2014-03-11 | Dow Agrosciences, Llc. | Compounds and compositions |
| US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
| US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
| EP2950644B1 (en) | 2013-01-30 | 2017-07-19 | AgroFresh Inc. | Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts |
| US9585396B2 (en) | 2013-01-30 | 2017-03-07 | Agrofresh Inc. | Volatile applications against pathogens |
| WO2015026548A1 (en) * | 2013-08-20 | 2015-02-26 | 3M Innovative Properties Company | Boron-silane polyether complex |
| KR101756785B1 (ko) * | 2015-03-10 | 2017-07-12 | 한국화학연구원 | 4배위 유기 붕소 화합물의 제조방법 |
| EP3426029B1 (en) | 2016-03-07 | 2023-08-30 | AgroFresh Inc. | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
| US11447506B2 (en) | 2016-05-09 | 2022-09-20 | Anacor Pharmaceuticals, Inc. | Crystal forms of crisaborole in free form and preparation method and use thereof |
| IL248149B (en) | 2016-09-29 | 2020-03-31 | Garti Nissim | Formulations of dilutable cannabinoids and processes for their preparation |
| IL248150B (en) | 2016-09-29 | 2018-05-31 | Garti Nissim | A method for selective extraction of cannabinoid from plant origin |
| KR102465919B1 (ko) | 2016-10-05 | 2022-11-10 | 더 글로벌 얼라이언스 포 티비 드러그 디벨롭먼트, 잉크. | 미코박테리아 감염의 치료를 위한 헤테로아릴트리플루오로보레이트 화합물 |
| MA52337A (fr) | 2017-03-01 | 2021-03-03 | Anacor Pharmaceuticals Inc | Nouveaux analogues d'oxaborole et utilisations de ces derniers |
| AU2018230580A1 (en) * | 2017-03-09 | 2019-09-19 | The Penn State Research Foundation | Boron-containing small molecules for inhibiting activity of a receptor-like protein tyrosine phosphatase |
| CA3110179A1 (en) * | 2018-08-20 | 2020-02-27 | Senseonics, Incorporated | Mediated drug release for reducing in vivo analyte indicator degradation |
| US20230340530A1 (en) | 2020-08-31 | 2023-10-26 | Pfizer Inc. | Methods of Protecting RNA |
| US12357552B2 (en) | 2021-03-09 | 2025-07-15 | Juris GERMANAS | Hydroxyquinoline compounds and methods of use as pigment modifying agents |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR950012756B1 (ko) * | 1989-10-18 | 1995-10-21 | 훽스트 아크티엔게젤샤프트 | 벼의 잡초의 방제방법 |
| US5348947A (en) * | 1993-05-07 | 1994-09-20 | American Cyanamid Company | Diarylboron ester and thioester fungicidal agents |
| US5348948A (en) * | 1993-05-07 | 1994-09-20 | American Cyanamid Company | 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal |
| JPH0952893A (ja) * | 1995-08-10 | 1997-02-25 | Yoshitomi Pharmaceut Ind Ltd | キノロンカルボン酸誘導体の工業的な製造法およびその合成中間体 |
| DE19829947A1 (de) * | 1998-07-04 | 2000-01-05 | Bayer Ag | Elektrolumineszierende Anordnungen mit Bor-Chelaten |
| WO2000044387A1 (fr) * | 1999-01-29 | 2000-08-03 | Nitto Kasei Co., Ltd. | Composes organobores presentant une activite de coccidiostats |
| CN1370170A (zh) * | 1999-05-25 | 2002-09-18 | 宾夕法尼亚州研究基金会 | Dna甲基转移酶抑制剂 |
| DE10110051C2 (de) * | 2001-03-02 | 2003-07-03 | Clariant Gmbh | Verfahren zur Herstellung von Boron- und Borinsäuren |
| JP2002322007A (ja) * | 2001-04-27 | 2002-11-08 | Shionogi & Co Ltd | 有機ホウ素化合物を含有する植物用殺線虫剤 |
| CA2473238A1 (en) * | 2002-01-10 | 2003-07-24 | The Penn State Research Foundation | Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids |
| CA2509645A1 (en) * | 2002-12-18 | 2004-07-08 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
| US7390806B2 (en) * | 2002-12-18 | 2008-06-24 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
-
2003
- 2003-12-18 CA CA002509645A patent/CA2509645A1/en not_active Abandoned
- 2003-12-18 NZ NZ540870A patent/NZ540870A/en not_active IP Right Cessation
- 2003-12-18 BR BR0317564-2A patent/BR0317564A/pt not_active IP Right Cessation
- 2003-12-18 KR KR1020057011194A patent/KR20050084378A/ko not_active Ceased
- 2003-12-18 EP EP03800095A patent/EP1581500A4/en not_active Withdrawn
- 2003-12-18 JP JP2005502662A patent/JP2006511613A/ja not_active Withdrawn
- 2003-12-18 MX MXPA05006685A patent/MXPA05006685A/es active IP Right Grant
- 2003-12-18 AU AU2003299821A patent/AU2003299821B2/en not_active Ceased
- 2003-12-18 EP EP08155302A patent/EP1980564A1/en not_active Withdrawn
- 2003-12-18 US US10/740,304 patent/US20040224923A1/en not_active Abandoned
- 2003-12-18 WO PCT/US2003/040982 patent/WO2004056322A2/en not_active Ceased
- 2003-12-18 CN CN2010101656749A patent/CN101928295A/zh active Pending
-
2007
- 2007-09-06 US US11/851,259 patent/US20080146803A1/en not_active Abandoned
-
2009
- 2009-02-02 JP JP2009021716A patent/JP2009161540A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009161540A (ja) | 2009-07-23 |
| JP2006511613A (ja) | 2006-04-06 |
| CN101928295A (zh) | 2010-12-29 |
| AU2003299821A1 (en) | 2004-07-14 |
| US20040224923A1 (en) | 2004-11-11 |
| WO2004056322A3 (en) | 2004-09-16 |
| EP1581500A2 (en) | 2005-10-05 |
| KR20050084378A (ko) | 2005-08-26 |
| CA2509645A1 (en) | 2004-07-08 |
| US20080146803A1 (en) | 2008-06-19 |
| WO2004056322A2 (en) | 2004-07-08 |
| NZ540870A (en) | 2008-09-26 |
| EP1980564A1 (en) | 2008-10-15 |
| BR0317564A (pt) | 2005-11-22 |
| EP1581500A4 (en) | 2008-03-05 |
| AU2003299821B2 (en) | 2010-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05006685A (es) | Antibioticos que contienen complejos de acido borinico y metodos de uso. | |
| TW200612939A (en) | Antibiotics containing borinic acid complexes and methods of use | |
| SG149043A1 (en) | N,n-dihalogenated amino acids and derivatives | |
| TW200503674A (en) | Therapeutic agents | |
| GB0022438D0 (en) | Organic Compounds | |
| NZ543661A (en) | Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation | |
| TW200612966A (en) | Boron-containing compounds and methods of use | |
| TW200510392A (en) | Chemical compounds | |
| WO2005030753A3 (en) | Therapeutic agents useful for treating pain | |
| GB0402809D0 (en) | Chemical compounds | |
| TW200505452A (en) | Chemical compounds | |
| GB0416508D0 (en) | Therapeutic agents | |
| PT1765360E (pt) | Utilizações antivirais de complexos de ácido borínico | |
| MXPA05011785A (es) | Moduladores positivos de receptores de acetilcolina nicotinicos. | |
| MXPA05014184A (es) | Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral. | |
| MXPA06007007A (es) | Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores. | |
| TW200700420A (en) | Novel triazolopyrimidine derivatives | |
| AU2002223796A1 (en) | Pleuromutilin derivatives with antimicrobial activity | |
| WO2007125383A3 (en) | Topical drug delivery by iontophoresis | |
| TW200610530A (en) | Anti-parasitic uses of borinic acid complexes | |
| MXPA06000137A (es) | Mezclas fungicidas. | |
| TW200700421A (en) | Novel triazolopyrimidine derivatives | |
| WO2006138589A3 (en) | Opioid receptor ligands | |
| MXPA05006378A (es) | Compuestos esteroides con actividad anti-tumoral. | |
| TW200517057A (en) | Fungicidal mixtures |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |